You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 11, November 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (13)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Alzheimer Disease
 •Neurogenetics
 •Alert me on articles by topic

Identification of New Presenilin Gene Mutations in Early-Onset Familial Alzheimer Disease

Andrea Tedde, PhD; Benedetta Nacmias, PhD; Monica Ciantelli, MD; Paolo Forleo, MD; Elena Cellini, PhD; Silvia Bagnoli, PhD; Carolina Piccini, MD; Paolo Caffarra, MD; Enrico Ghidoni, MD; Marco Paganini, MD; Laura Bracco, MD; Sandro Sorbi, MD

Arch Neurol. 2003;60:1541-1544.

Background  Mutations in the presenilin 1 (PS1) and presenilin 2 (PS2) genes, and more rarely in {beta}-amyloid precursor protein ({beta}APP), underlie the pathogenesis of most cases of familial Alzheimer disease (FAD).

Objective  To screen the entire coding region of the PS1 and PS2 genes and exons 16 and 17 of the {beta}APP to find pathogenetic mutations in FAD.

Patients  Patients with FAD were consecutively enrolled from among the outpatients from the neurology departments at the Universities of Florence and Parma and the Santa Maria Nuova Hospital in Reggio Emilia, Italy.

Design and Methods  Polymerase chain reaction–single-strand conformation polymorphism and DNA se-quencing were used to investigate the affected members of families with FAD.

Results  We identified a family carrying a novel Ser130Leu mutation in the PS2 gene. Moreover, we found 2 novel PS1 mutations: Cys92Ser in exon 4 in 2 unrelated families and Leu174Met in exon 6 in the PS1 gene. We also found a fourth Italian family with the {beta}APP Val717Ile mutation.

Conclusions  One novel PS2 mutation associated with highly penetrant but variable age at onset (35-85 years) and 2 novel PS1 missense mutations associated with early-onset Alzheimer disease at age 49 to 54 years have been identified in Italian families. Screening for new mutations in presenilin and {beta}APP genes was beneficial in characterizing gene function in FAD.


From the Department of Neurological and Psychiatric Sciences, University of Florence, Italy (Drs Tedde, Nacmias, Ciantelli, Forleo, Cellini, Bagnoli, Piccini, Paganini, Bracco, and Sorbi); Institute of Neurology, University of Parma, Italy (Dr Caffarra); and the Neurological Department, Santa Maria Nuova Hospital, Reggio Emilia, Italy (Dr Ghidoni).


RELATED ARTICLE

Alzheimer Disease Genes: Presenilin 2 Mutation Number 9 and Still Counting
Gerard D. Schellenberg
Arch Neurol. 2003;60(11):1521-1522.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hypometabolism Exceeds Atrophy in Presymptomatic Early-Onset Familial Alzheimer's Disease
Mosconi et al.
JNM 2006;47:1778-1786.
ABSTRACT | FULL TEXT  

Contribution of Presenilin Transmembrane Domains 6 and 7 to a Water-containing Cavity in the {gamma}-Secretase Complex
Tolia et al.
J. Biol. Chem. 2006;281:27633-27642.
ABSTRACT | FULL TEXT  

Alzheimer Disease Genes: Presenilin 2 Mutation Number 9 and Still Counting
Schellenberg
Arch Neurol 2003;60:1521-1522.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.